Deviation Case Studies

The initial signs of an unapproved chromatographic integration often appear during the routine review of stability analysis data. Symptoms may include:Click to read the full article.

The initial symptoms that led to the discovery of the unauthorized method modification included:Click to read the full article.

In this case, the issue was first flagged by laboratory analysts who noticed discrepancies between chromatographic results during method transfer from R&D to QC labs. Key symptoms included:Click to read…

The initial indicator of a potential system suitability failure was an inconsistency in the chromatographic data generated during the stability analysis of a novel pharmaceutical product. Operators noticed that the…

During routine quality control data review, unexpected results were flagged by QC analysts. These results deviated from validated analytical method specifications, raising immediate concerns about data integrity and method compliance.…

During a routine FDA inspection, several indicators prompted further scrutiny of the laboratory’s sample preparation processes. Observers noted discrepancies in sample concentrations when compared with established reference standards. Specifically, the…

In this case study, the incident was primarily identified through a series of unexpected results during the routine stability analysis of a drug product formulation. The symptoms included:Click to read…

During a routine audit of stability testing, analysts discovered discrepancies in the analytical results compared to the historical data of earlier batches. The laboratory faced the following symptoms:Click to read…

During a routine FDA inspection at a mid-sized pharmaceutical company, several deviations were identified related to stability analysis results for an oncology product. The primary symptoms included:Click to read the…

In our scenario, the symptoms began to surface through routine testing of a critical drug product. Quality Control analysts detected an increasing frequency of OOS results for a particular stability…

The initial detection of the unapproved chromatographic integration arose during a routine quality control audit. Analysts noted discrepancies between the chromatographic results produced and the expected outcomes based on historical…

In this case, the laboratory faced discrepancies in the testing records of a batch of a drug product under review. Symptoms indicated a lack of alignment between the physical test…